Crossmark

Efficacy of armodafinil in moderate to severe obstructive sleep apnea patients with excessive daytime sleepiness after suboptimal usage of continuous positive airway pressure treatment: a prospective study

Crossref DOI link: https://doi.org/10.1007/s11325-025-03448-3

Published Online: 2025-09-04

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ngeyvijit, Jinjuta

Desudchit, Tayard

Dadphan, Nattapot

Aswanetmanee, Pantaree

Muntham, Dittapol

Chirakalwasan, Naricha https://orcid.org/0000-0002-0945-3757
Funding

Funding for this research was provided by:

Chulalongkorn University
License Information

Text and Data Mining valid from 2025-09-04

Version of Record valid from 2025-09-04
More Information

Article History

Received: 14 June 2025

Revised: 10 August 2025

Accepted: 15 August 2025

First Online: 4 September 2025

Declarations

:

: The study was approved by institutional review board (IRB) of Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

: Research protocol was approved by ethic committee of Faculty of Medicine, Chulalongkorn University and was performed in accordance with the principles of Declaration of Helsinki.

: All patients provided written informed consent before participation. The study was registered at (TCTR20210218005).

: All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Document is current

Any future updates will be listed below